Tumour necrosis factor-α in cardiac inflammation: friend or foe?
Author:
Affiliation:
1. Faculty of Medicine and Dentistry, William Harvey Research Institute, Barts and The London SMD, Queen Mary University of London, Charterhouse Square , London EC1M 6BQ , UK
Publisher
Oxford University Press (OUP)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology
Link
https://academic.oup.com/cardiovascres/advance-article-pdf/doi/10.1093/cvr/cvad180/55049107/cvad180.pdf
Reference10 articles.
1. Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL);Mann;Circulation,2004
2. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial;Chung;Circulation,2003
3. Overexpression of tumor necrosis factor (TNF)α and TNFα receptor I in human viral myocarditis: clinicopathologic correlations;Calabrese;Mod Pathol,2004
4. TNF-α Inhibitors and other biologic agents for the treatment of immune checkpoint inhibitor-induced myocarditis;Liu;Front Immunol,2022
5. Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis;Setoguchi;Am Heart J,2008
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3